Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  17 results for ""Reperfusion Injury drug therapy""

Your Filters

Content Provider : Gale Business
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
News

Revive Therapeutics Files for FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation.

  • Source: GlobeNewswire. 2021.

Record details

Read More Add to Saved list
×
Periodical

Congenia phase change I, Netherlands (reperfusion injury).

  • Source: R & D Focus Drug News. 2013.

Record details

Read More Add to Saved list
×
Periodical

Astellas discontinued.

  • Source: R & D Focus Drug News. 2013.

Record details

Read More Add to Saved list
×
Periodical

Stealth Peptides clinical data (Phase I) (reperfusion injury).

  • Source: R & D Focus Drug News. 2011.

Record details

Read More Add to Saved list
×
Periodical

Trophos phase change I, France (reperfusion injury).

  • Source: R & D Focus Drug News. 2010.

Record details

Read More Add to Saved list
×
Periodical

ADC 1004 Alligator Bioscience developing therapy for reperfusion injury.

  • Source: R & D Focus Drug News. 2009.

Record details

Read More Add to Saved list
×
Periodical

NP 202 Neuprotect partnering opportunity, Worldwide.

  • Source: R & D Focus Drug News. 2007.

Record details

Read More Add to Saved list
×
Periodical

KAI 9803 KAI Pharmaceuticals clinical data (phase II) (reperfusion injury).

  • Source: R & D Focus Drug News. 2007.

Record details

Read More Add to Saved list
×
Periodical

RX 207 Rimonyx pc preclinical, Israel.

  • Source: R & D Focus Drug News. 2006.

Record details

Read More Add to Saved list
×
Periodical

CLK-1 targeted therapy, Chronogen Chronogen preclinical data.

  • Source: R & D Focus Drug News. 2005.

Record details

Read More Add to Saved list
×
  • 1-10 of  17 results for ""Reperfusion Injury drug therapy""